INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![Two views of risk]( "Two Views Of Risk When Choosing An IRT/RTSM Software Partner")
Two Views Of Risk When Choosing An IRT/RTSM Software PartnerIn this clip, Ryan Keane of Korio explains why legacy RTSM vendors, designed for large pharmaceutical companies, often struggle to serve smaller, fast-moving Sponsors.
-
![mobile online banking and payment GettyImages-1195693419]( "Cutting-Edge Tech Improving Global Participant Payment Paradigms")
Cutting-Edge Tech Improving Global Participant Payment ParadigmsParticipant payment management is essential for successful global clinical trials, as it enables diverse regulatory compliance, enhances participant satisfaction, and streamlines execution.
-
![Advanced Drug Delivery And Drug Device Combination Product Solutions]( "Advanced Drug Delivery And Drug Device Combination Product Solutions")
Advanced Drug Delivery And Drug Device Combination Product SolutionsPCI Pharma Services' end-to-end injectable services, comprehensive approach, and dedication to excellence provide convenient, easy-to-use, patient-centric therapies.
-
![cro-vendor-selection-GettyImages-1220794892]( "How Smaller Biotechs Are Rethinking CRO Relationships Post-Pandemic")
How Smaller Biotechs Are Rethinking CRO Relationships Post-PandemicSmaller biotechs are rethinking CRO partnerships, valuing speed, scientific access, flexibility, and transparent pricing over scale — driven by pandemic lessons and a sharper focus on operational fit.
-
Clinical Trial Payments At Scale: Volume And Control2/4/2026
Find an operational explanation of what payment scale actually means in clinical trials, why small-study approaches break down, and how volume reshapes compliance, reporting, and automation decisions.
-
A Guide To Patient Reimbursements And Payments9/13/2024
Delayed or inadequate payments can harm patient retention and site efficiency. Learn how sponsors can mitigate financial toxicity, streamline reimbursement, and ensure a positive experience for all involved.
-
ICON And Medable Drive 85% eConsent Adoption In U.S. Menopause Study4/1/2026
A site-focused strategy drove strong eConsent adoption in a complex women’s health study, showing how tailored training and hands-on support boost engagement and compliance.
-
The ctDNA Clinical Trial Advantage5/27/2026
See how CROs are helping shape the future of ctDNA research—translating emerging data, regulatory insights, and biomarker innovation into faster, smarter oncology development.
-
Biopharma Giant Streamlines Infrastructure With Proprietary Software11/17/2025
Archiving legacy QMS systems into a centralized platform reduced costs, simplified access, and improved efficiency for a global diagnostics company undergoing quality process harmonization.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![Business Merger GettyImages-1215758851]( "Global Consulting Powered By Relevant Experience")
Solve mission critical challenges and bring life-changing therapies to patients faster with Advarra Consulting.
-
![Business People Celebrating-GettyImages-1491196684]( "From Innovation To Patient Impact")
Biotech innovation is redefining the future of healthcare — but translating breakthroughs into patient impact requires the right partner.
-
![GettyImages-1382353763-computer-medical-documents-review]( "An Easy-to-Use Analytics Platform For Clinical Trial Vendor Selection And Management")
ClinAI helps you centralize RFPs, budgets, and vendor data—so you can select the right partners, manage change orders, and keep your studies on track.
-
![GettyImages-887882750 global consulting]( "Portfolio Optimization Strategic Consulting")
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
-
![GettyImages-1498418424-australia-sydney]( "Why Australia Is The Best Place In The World For Early Phase Studies")
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
